Prevention of Invasive Pneumococcal Disease Among Black or African American Children With and Without Sickle Cell Disease in the United States After Introduction of 13‐Valent Pneumococcal Conjugate Vaccine, 2005 Through 2019
Despite reductions in IPD incidence after PCV13 introduction, children with SCD are at increased risk of IPD compared to children without SCD. Use of higher valency PCVs may help reduce remaining IPD burden.
Authors
- Mary Hulihan
- Lesley McGee (ORCID: https://orcid.org/0000-0001-8214-921X)
- Miwako Kobayashi
- Ryan Gierke
- Amanda B. Payne (ORCID: https://orcid.org/0000-0003-1027-7639)
- Thomas V. Adamkiewicz (ORCID: https://orcid.org/0000-0001-5830-9287)
- Wei Xing (ORCID: https://orcid.org/0009-0002-4548-0207)
Institutions
- Centers for Disease Control and Prevention (US)
- National Center for Immunization and Respiratory Diseases (US)
- National Center on Birth Defects and Developmental Disabilities (US)
- Morehouse School of Medicine (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1002/pbc.31467
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00